Vaxart (NASDAQ:VXRT) has priced its public offering of 9.1M common shares (including pre-funded warrants to purchase up to 8.2M common stock), and common warrants to purchase the same amount of shares at $1.10 per share and warrant, for gross proceeds of ~$10M.
Each warrant will have an exercise price of $1.10 per share and will expire five years from the date of issuance.
Underwriters over-allotment is an additional 1,363,636 shares and/or warrants.
Closing date is April 11.
Shares are down 35% premarket.
Try Seeking Alpha PREMIUM for unlimited analysis on VXRT